TEST BANK For Psychopharmacology Drugs the Brain and Behavior 3rd Edition By Meyer Nursing, Verified Chapters 1 - 20

Chapter 1. Principles of Pharmacology Chapter 2. Structure and Function of the Nervous System Chapter 3. Chemical Signaling by Neurotransmitters and Hormones Chapter 4. Methods of Research in Psychopharmacology Chapter 5. Catecholamines Chapter 6. Serotonin Chapter 7. Acetylcholine Chapter 8. Glutamate and GABA Chapter 9. Drug Abuse and Addiction Chapter 10. Alcohol Chapter 11. The Opioids Chapter 12. Psychomotor Stimulants: Cocaine, Amphetamine, and Related Drugs Chapter 13. Nicotine and Caffeine Chapter 14. Marijuana and the Cannabinoids Chapter 15. Hallucinogens, PCP, and Ketamine Chapter 16. Inhalants, GHB, and Anabolic-Androgenic Steroids Chapter 17. Disorders of Anxiety and Impulsivity and the Drugs Used to Treat These Disorders Chapter 18. Affective Disorders: Antidepressants and Mood Stabilizers Chapter 19. Schizophrenia: Antipsychotic Drugs Chapter 20. Neurodegenerative Diseases WWW.THENURSINGMASTERY.COM Page 3 of 247 Chapter 1: Principles of Pharmacology Multiple Choice 1. refer(s) to specific molecular changes that occur when a drug binds to a particular target site or receptor, while are the resulting widespread alterations in function. a. Drug action; therapeutic effects b. Side effects; drug effects c. Therapeutic effects; side effects d. Drug action; drug effects ANSWER: d Textbook Reference: Pharmacology: The Science of Drug Action 2. After drug administration has occurred, the amount of drug in the blood that is free to bind at specific target sites is referred to as a. the therapeutic dose. b. first-pass effects. c. bioavailability. d. ED50. ANSWER: c Textbook Reference: Pharmacokinetic Factors Determining Drug Action 3. The specific molecular changes that occur when a drug binds to a particular target site or receptor are referred to as a. drug effects. b. drug action. c. side effects. d. placebo effects. WWW.THENURSINGMASTERY.COM Page 4 of 247 ANSWER: b Textbook Reference: Pharmacology: The Science of Drug Action 4. Which of the following is not a possible explanation for placebo effects? a. Pavlovian conditioning b. Genetic variation c. Drug competition d. Expectation of outcome ANSWER: c Textbook Reference: Pharmacology: The Science of Drug Action WWW.THENURSINGMASTERY.COM Page 5 of 247 5. The administration of oxytocin has been proposed as a treatment for autism. a. intravenous b. oral c. intranasal d. intracerebral ANSWER: c Textbook Reference: Pharmacokinetic Factors Determining Drug Action 6. Which factor does not affect the pharmacokinetics of a drug? a. Route of administration b. Lipid solubility c. Depot binding d. Drug action ANSWER: d Textbook Reference: Pharmacokinetic Factors Determining Drug Action 7. First-pass metabolism occurs when drugs are taken a. orally. b. intravenously. c. subcutaneously. d. nasally. ANSWER: a Textbook Reference: Pharmacokinetic Factors Determining Drug Action 8. The area postrema is one area in the brain where the is not complete. a. cerebrospinal fluid b. blood–brain barrier c. choroid plexus d. phospholipid membrane ANSWER: b Textbook Reference: Pharmacokinetic Factors Determining Drug Action WWW.THENURSINGMASTERY.COM Page 6 of 247 9. First-pass metabolism occurs with orally administered drugs because a. their absorption is slowed by food. b. drugs absorbed into the bloodstream from the stomach go to the liver on the way to general circulation. c. drugs must first survive the acidic environment of the stomach. d. salivary enzymes in the mouth begin the process of metabolism. ANSWER: b Textbook Reference: Pharmacokinetic Factors Determining Drug Action 10. Toxic substances in the blood trigger a vomiting response by activating the a. blood–brain barrier. b. choroid plexus. c. area postrema. d. median eminence. WWW.THENURSINGMASTERY.COM Page 7 of 247 ANSWER: c Textbook Reference: Pharmacokinetic Factors Determining